MATERIAL MANAGEMENT IN PHARMA

Material Management in Pharma: The Backbone of GMP Compliance

In pharma, “material” means everything that goes into or touches your product: APIs, excipients, packaging components, labels, even cleaning agents. If material management fails, batch fails. USFDA 483s and Schedule M non-compliances often start in the warehouse, not production.

Material management in pharma is not just “store and issue”. It’s a GMP-controlled process from receipt to issue to production. This blog covers the full cycle: RM/PM handling, FIFO vs FEFO, quarantine, sampling, and how to stay audit-ready.

1. What is Material Management in Pharmaceutical Industry?

As per Schedule M Clause 10 + WHO GDP guidelines, material management covers 7 steps:

1. Purchase: Approved vendor list, specifications, PO with correct details
2. Receipt: Physical + document verification at gate
3. Quarantine: “Hold” status until QC approval. No material moves to production
4. Sampling: By QC as per sampling SOP to prevent contamination
5. Testing & Release: QC approves/rejects based on COA vs spec
6. Storage: Correct temperature, humidity, segregation, labeling
7. Issue/Dispense: To production with FIFO/FEFO + full traceability

If any 1 step is weak, data integrity and product quality both suffer.

2. Key Types of Materials & Their Control

2.1 Raw Materials – RM

APIs + excipients. Highest risk. Each lot needs COA from supplier + testing by QC. Storage conditions are critical: e.g. “Store below 25°C” or “Protect from moisture”. Use dehumidifiers in warehouse if needed.

2.2 Packaging Materials – PM

Strips, blisters, cartons, labels, leaflets. 2 big GMP risks here: 1. Mix-up of labels 2. Missing batch no/expiry printing. That’s why PM is stored in separate “Packaging Store” with limited access.

2.3 Printed Packaging Materials

Labels, cartons, leaflets with batch no, MRP, expiry. These are “critical materials”. Schedule M treats them like RM. Issued only after batch card is approved. Any excess must be accounted for + destroyed under QA supervision.

3. FIFO vs FEFO: Which One Does Pharma Use?

Concept	Meaning	Pharma Rule
FIFO	First In, First Out	Used for general items like cartons, gloves
FEFO	First Expiry, First Out	Mandatory for RM, PM, APIs. Issue material with nearest expiry first

Why FEFO? Because an API with 3 months left cannot be used even if it arrived last month. USFDA + Schedule M both insist on FEFO for anything that impacts product quality/shelf life.

MES/ERP helps: System will not allow issue of Lot B if Lot A with earlier expiry is still in stock.

4. Quarantine, Sampling & Release: The GMP Triangle

4.1 Quarantine Area

Every incoming material must go to “Quarantine” first. Physically segregated + labeled “QUARANTINE – NOT FOR USE”. Color coding helps: Yellow label = Quarantine, Green = Approved, Red = Rejected.

Common audit finding: “Quarantine material stored with approved material”. Physical segregation is non-negotiable.

4.2 Sampling by QC

Sampling must happen in dedicated “Sampling Booth” with HEPA filtration for RM. Prevents cross-contamination. Sampler wears PPE, uses dedicated scoops per material.

Sample size is defined in SOP. Too little = OOS risk. Too much = material loss.

4.3 Release to “Approved” Status

Only after QC gives “Release” in LIMS + QA approves, warehouse changes status to “Approved”. ERP/MES updates label from yellow to green. Only then can production indent it.

5. Storage Conditions & Warehouse GMP

1. Temperature mapping: Warehouse must be qualified. Hot spots/cold spots identified. Keep temp/humidity recorders 24×7
2. Palletization: Material should not touch floor/wall. 10cm gap from floor, 45cm from wall per GDP
3. Segregation: Beta-lactams, hormones, cytotoxic drugs stored in separate rooms. Prevents cross-contamination
4. Labeling: Every drum/box must have: Material name, Code, Batch no, Mfg date, Exp date, Status label

6. Common Audit Observations in Material Management

1. No vendor approval: Using unapproved vendor for API to save cost = major 483
2. Over-issue of material: Production takes 105kg when BMR says 100kg. No justification recorded
3. Missing reconciliation: Labels issued = 100,000. Labels used + destroyed = 98,500. 1,500 missing with no investigation
4. Expired material in stock: FEFO not followed. Material expired in warehouse = product recall risk
5. No status labels: Drums without “Approved/Rejected” tag. Operator can’t know if it’s safe to use

7. Role of ERP/MES/WMS in Modern Material Management

Manual register + Excel = human error risk. Modern plants use:

• WMS – Warehouse Management System: Tracks bin location, auto-allocates FEFO lots
• ERP: Links purchase → receipt → QC → issue → production
• Barcode/RFID: Scan drum barcode before issue. System blocks wrong material/lot

Result: 99.9% accuracy, faster batch release, audit trail for every movement. This is what USFDA means by “data integrity by design”.

Key Takeaway for QA & Warehouse Teams

Material management is where GMP starts. You can have perfect manufacturing, but if wrong API lot is dispensed, entire batch is scrap + patient risk.

3 rules to remember: Segregate, Label, FEFO. If you follow these + have strong documentation, 80% of warehouse-related audit findings disappear.

As Schedule M says: “Materials shall be purchased, stored, and handled in such a manner that quality is maintained”. That one line covers your entire warehouse SOP.

---